Anti-human LCN2 Antibody, Mouse mAb, clone 2C3
Monoclonal Antibody against Human LCN2
Size: 0.1 mg
Lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), 24p3, or neutrophil lipocalin (NL), is a 25-kDa secretory glycoprotein . LCN2 has been implicated in a variety of cellular processes including the innate immune response, differentiation, tumorigenesis, and cell survival [2-3]. It appears to be upregulated in various inflammation and infection conditions. Several reports suggest that LCN2 may represent a sensitive biomarker for various renal injuries  and is associated with several types of cancers, including breast cancer , ovarian, colorectal, and pancreatic cancers [6-7]. Furthermore, a growing body of evidence suggests that serum levels of LCN2 are correlated with obesity, insulin resistance, hyperglycemia, coronary heart disease and fatty liver disease in humans [8-11].
Recombinant full-length human lipocalin-2 (Cat. No: 41050) in E.coli.
The antibody detects human LCN2.
Protein G affinity purification
Liquid in phosphate-buffered saline (PBS).
Store at –20°C for less than one week. For long-term storage, aliquot and freeze at -70°C. Avoid repeated freeze/defrost cycles.
This antibody can be used as a capture antibody in a human lipocalin-2 ELISA in combination with monoclonal anti-human lipocalin-2 antibody clone 2C3 (Cat. No.: 21050) as detection antibody.
 Kjeldsen, L. et al. (1993) J. Biol. Chem. 268:10425-32
 Yang, J. et al. (2002) Mol. Cell. 10:1045-56.
 Flo, T.H. et al. (2004) Nature 432:917-21.
 Mishra, J. et al. (2005) Lancet 365:1231-6.
 Yang, J. et al. (2009) Proc Natl Acad Sci U S A 106(10):3913-8.
 Hanai, J. et al. (2005) J. Biol. Chem. 280:13641-7.
 Lee, H.J. et al. (2005) Int. J. Cancer 118:2490-7.
 Wang Y, et al. (2007) Clin Chem 53(1):34-41.
 Yan QW, et al. (2007) Diabetes 56(10):2533-40.
 Ruby LC Hoo, et al. (2008) Expert Rev. Endocrinol Metal 3(1):29-41.
 Milner KL, et al. Hepatology [Epub ahead of print].